Novartis Investigative Site

Glasgow - Scotland G12 OYN

0 studies enrolling now · 7 studies all time

What they study most

Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Allergic Asthma, Asthma, Breast Cancer, Chronic Myelogenous Leukemia, Chronic Pain, Hepatitis C, Hypereosinophilic Syndrome, Leukemia, Systemic Mastocytosis

Studies at this site

• A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies — Completed
• Dose Finding Study for QAW039 in Asthma — Completed
• Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia — Completed
• A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation — Completed
• Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants — Completed
• Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients — Completed
• Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists — Completed